Tumor-Induced Osteomalacia (TIO)
3 clinical trials · Condition
◉ Watch Tumor-Induced Osteomalacia (TIO)
| Record | Firm | Date |
|---|---|---|
| Tumor-induced Osteomalacia Disease Monitoring Program (NCT04783428) | Ultragenyx Pharmaceutical Inc | 2022-01-31 |
| Study of Burosumab (KRN23) in Adults With Tumor-Induced Osteomalacia (TIO) or Epidermal Nevus Syndrome (ENS) (NCT02304367) | Kyowa Kirin, Inc. | 2015-03-24 |
Track Tumor-Induced Osteomalacia (TIO) automatically
Every clearance here is in the API, with alerts when new ones post.